Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IBC 293 is selective for GPR109B over niacin receptor GPR109A. IBC 293 is a highly selective agonist for GPR109B, a human orphan G-protein-coupled receptor expressed in adipocytes.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 9,000 | |||
10 mg | 在庫あり | ¥ 13,000 | |||
25 mg | 在庫あり | ¥ 22,500 | |||
50 mg | 在庫あり | ¥ 34,000 | |||
100 mg | 在庫あり | ¥ 45,500 | |||
500 mg | 在庫あり | ¥ 112,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 10,000 |
説明 | IBC 293 is selective for GPR109B over niacin receptor GPR109A. IBC 293 is a highly selective agonist for GPR109B, a human orphan G-protein-coupled receptor expressed in adipocytes. |
別名 | IBC293, IBC-293 |
分子量 | 205.21 |
分子式 | C10H11N3O2 |
CAS No. | 306935-41-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/ml (268.02 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IBC 293 306935-41-1 Endocrinology/Hormones GPCR/G Protein GPR GPR109b GPR109A HCAR2 IBC293 PUMA-G Inhibitor GPR109 receptor agonist-1 HCA2 inhibit cardio-metabolic diseases IBC-293 HM74A inhibitor